Envometinib
Envometinib (Compound B) is a dual-MEK inhibitor that works through Deep Cyclic Inhibition (DCI). Envometinib has antitumor activity in various in vivo models. Envometinib can be studied in RAS and RAF mutated cancer such as colorectal cancer and melanoma.
For research use only. We do not sell to patients.
- CAS No.: 2952542-22-0
- Formula: C23H27ClN4O6S
- Molecular Weight:523.00
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
All MEK Isoforms
More
Biological Activity
Chemical Information
-
CAS No. 2952542-22-0
-
Molecular Weight 523.00
-
Formula C23H27ClN4O6S
-
SMILES
CN(CC(C1=C(OC2=O)C=C(OC(N(C)C)=O)C=C1)=C2CC3=C(C(NS(NC)(=O)=O)=CC=C3)Cl)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Envometinib Related Classifications
HY-177081 Related Classifications
Powered by Bioz